İNFERTİLİTE TEDAVİSİ VE JİNEKOLOJİK KANSER İLİŞKİSİ

Yıl 2020, Cilt: 23 Sayı: 3, 452 - 461, 30.09.2020

Özen İnam , İlkay Güngör Satılmış

https://doi.org/10.17049/ataunihem.589502

Öz

Amaç: İnfertilite oranı gerek Türkiye’de gerekse dünyada gün geçtikçe artmaktadır. Yapılan bu sistematik derleme ile de artan “infertilite tedavisi ile jinekolojik kanserler arasında ilişki” olup olmadığına dair son beş yıl içerisinde yapılmış olan kohort ve vaka-kontrol araştırmalarını incelemek amaçlanmıştır.
Yöntem: Çalışma, 2014-2019 yılları arasında “infertilite tedavilerinin jinekolojik kanserler üzerindeki etkileri ile ilgili yapılmış olan” araştırmaların geriye dönük taranması ile yapılmıştır. Tarama yapılırken Türkçe veri tabanı için “infertilite tedavisi” ve “kanser”, yabancı veri tabanları için “infertility care”, “cancer” anahtar kelimeler kullanılmıştır. Bulunan makalelerin içlerinden jinekolojik olmayan kanserler ile yapılmış çalışmalar, araştırma olmayan derleme çalışmaları ve tez çalışmaları çıkarılmıştır. Araştırmada kohort çalışmalar ile vaka-kontrol çalışmaları alınacak şekilde kısıtlama yapılmıştır. On üç tane kaynak sistematik inceleme için ele alınmıştır. İçlerinden diğer çalışmalarla bütünlük göstermeyen iki çalışma ve tam metni bulunmayan bir çalışma elenmiş, 10 çalışmanın tam metin¬leri kaynak olarak alınmıştır.
Sonuç: İncelenen çalışmalar sonucunda; yardımcı üreme teknikleri (YÜT) tedavileri ile hormona bağımlı jinekolojik kanserlerde (meme, uterus, over kanserleri) hafif artışlar gözlenmiştir bununla beraber bu artışın infertilite durumu ile mi yoksa YÜT tedavileri ile mi ilişkili olduğu tam olarak netlik kazanmamıştır. Bu bağlamda elde edilen bulgular ışığında infertilite tedavisi gören kadınlarda; jinekolojik kanser riski konusunda daha ileri çalışmalar yapılmalı ve YÜT ile tedavi edilenlerin takibinin devam etmesi teşvik edilmelidir. 

Anahtar Kelimeler

İnfertilite, kadın, Meme kanseri, Over kanseri, Uterus kanseri

RELATIONSHIP BETWEEN INFERTILITY TREATMENT AND GYNECOLOGICAL CANCER

Öz

Aim: Infertility rate in both Turkey and the world has increased day by day. With this systematic review, it was aimed to examine the cohort and case-control studies conducted in the last five years regarding whether there is a relationship between infertility treatment and gynecological cancers.
Methods: The study was carried out by retrospective screening of the researches which were done about the effects of infertility treatments on gynecological cancers between 2014-2019. During the screening, the words "infertility treatment" and "cancer" were used for the Turkish database. Keywords “infertility care” and “cancer” were used for foreign databases. Articles made with non-gynecological cancers, reviews and thesis studies were removed. In the study, cohort studies and case-control studies were taken. Thirteen sources were handled for systematic review. Two studies that did not complement with other studies and one study without full text were excluded, and the full texts of ten studies were taken as the source.
Conclusion: The effects of such infertility treatments on gynecological cancers have been investigated in many studies. Although many studies have observed slight increases in hormone-dependent gynecological cancers, it is not clear whether this increase is due to infertility or ART treatments. As a result of the findings, in women receiving infertility treatment; more studies on the risk of gynecological cancer should be done. Follow-up of women treated with ART should be encouraged.

Anahtar Kelimeler

Infertility, female, breast cancer, ovary cancer, cancer of uterus

Kaynakça

• 1. Brinton L. Long-term effects of ovulationstimulating drugs on cancer risk. Reproductive BioMedicine Online 2007;15(1):38-44.
• 2. Williams CL, Jones ME, Swerdlow AJ, Botting BJ, Davies MC, Jacobs I, et al. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. British Medical Journal 2018;362:k2644.
• 3. Orgeas CC, Sanner K, Hall P, Conner P, Holte J, Nilsson SJ, et al. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. American Journal of Obstetrics and Gynecology 2009;200(1):72.e1-72.e7.
• 4. Cetin I, Cozzi V, Antonazzo P. Infertility as a Cancer Risk Factor – A Review. Placenta 2008;29(2):169-77.
• 5. Liat GL, Jaron R, Liraz O, Tzvia B, Shlomo M, Bruno L. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecological Endocrinology 2012;28(10):809-14.
• 6. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1-e34.
• 7. Taheripanah R, Balash F, Anbiaee R, Mahmoodi M, Sene AA. Breast Cancer and Ovulation Induction Treatments. Clinical Breast Cancer 2018;18(5):395-9.
• 8. Reigstad MM, Storeng R, Myklebust TA, Oldereid NB, Omland AK, et al. Cancer risk in women treated with fertility drugs according to parity status—a registry-based cohort study. American Association for Cancer Research 2016;26(6):953-62.
• 9. Reigstad MM, Larsen IK, Myklebust TA, Robsahm TE, Oldereid NB, Omland AK, et al. Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway. International Journal of Cancer 2015;136(5):1140-8.
• 10. Krul IM, Groeneveld E, Spaan M, van den Belt-Dusebout AW, Mooij TM, Hauptmann M, et al. Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment data. European Journal of Cancer 2015;51(1):112-20.
• 11. Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. Journal of Cancer Research and Clinical Oncology 2016;142(1):287-93.
• 12. Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, et al. Cancer risk among parous women following assisted reproductive technology. Human Reproduction 2015;30(8):1952-63.
• 13. Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, et al. Cancer in women after assisted reproductive technology. Fertility and Sterility 2015;104(5):1218-26.
• 14. Perri T, Lifshitz D, Sadetzki S, Oberman B, Meirow D, Ben-Baruch GB, et al. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertility and Sterility 2015;103(5):1305-12.
• 15. Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Human Reproduction Update 1996;2(1):63-75.
• 16. Çiçek Ö, Fata S. İnfertilite Tedavisi Jinekolojik Kanser Riskini Arttırıyor mu? Türkiye Klinikleri Doğum-Kadın Sağlığı ve Hastalıkları Hemşireliği - Özel Konular 2017;3(1):35-9.
• 17. Vlahos NF, Economopoulos KP, Fotiou S. Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 2010;24(1):39-50.
• 18. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, et al. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Human Reproduction 2013;28(10):2813-21.
• 19. Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Amit A. The possible association between in vitro fertilization treatments and cancer development. International Journal of Gynecologic Cancer 2003;13(1):23-7.
• 20. Kanakas N, Mantzavınos T. Fertility drugs and gynecologic cancer. Women's Health and Disease: Gynecologic, Endocrine, and Reproductive Issues 2006;1092(1):265-7